Fmoc-Ile-OH

Catalog No.: 
ACXFMN512
CAS No.: 
71989-23-6
Molecular Formula: 
C21H23NO4
Molecular Weight: 
353.42
Fmoc-Ile-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$158.00In stockInquiry
1000g98%$307.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-Ile-OH
IUPAC Name(((9H-fluoren-9-yl)methoxy)carbonyl)-L-isoleucine
MDL No.MFCD00037125
Molecular FormulaC21H23NO4
Molecular Weight353.42
SMILESCC[C@H](C)[C@@H](C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C13)=O
InChI KeyQXVFEIPAZSXRGM-DJJJIMSYSA-N
SynonymEN300-74033 | BRD-K24518485-001-01-0 | fluoren-9-ylmethyl N-(1-carboxy-2-methylbutyl)carbamate | Z1123720061 | N-.alpha.-Fmoc-L-isoleucine | N-Fmoc-Ile-OH ( N-Fmoc-L-isoleucine) | DTXSID801315561 | CS-W020667 | Fmoc-L-isoleucine | SCHEMBL119497 | L-Isoleu
CAS No.71989-23-6
PubChem CID2724629

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXFMN512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFWUZ548 route compound structure diagram
    ACFWUZ548443-79-8
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXFMN512 route product structure diagram
    ACXFMN51271989-23-6In Stock
Inquiry

2. ACXFMN512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXFMN512 route product structure diagram
    ACXFMN51271989-23-6In Stock
Inquiry

3. ACXFMN512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXFMN512 route product structure diagram
    ACXFMN51271989-23-6In Stock
Inquiry

Comments (0)